Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14949938 | 0.84 | CNR2 (0.35) | — | |
| SCHEMBL14949926 | 0.82 | — | — | |
| SCHEMBL3826384 | 0.82 | — | — | |
| SCHEMBL14949936 | 0.82 | SIGMAR1 (0.31) | — | |
| SCHEMBL1952223 | 0.82 | SIGMAR1 (0.33) | P2RX7 | |
| SCHEMBL3000948 | 0.80 | — | — | |
| SCHEMBL20970168 | 0.80 | — | — | |
| SCHEMBL16524440 | 0.79 | ALDH1A1 (0.32) | P2RX7 | |
| SCHEMBL1734830 | 0.79 | P2RX7 (0.39) | P2RX7 | |
| SCHEMBL3000956 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2794548-B1 | A CONTINUOUS PROCESS FOR THE CARBONYLATION OF ETHYLENE | LUCITE INT UK LTD (GB) | 2019-05-15 | — | — | EP | claimed |
| US-9382190-B2 | Continuous process for the carbonylation of ethylene | LUCITE INTERNATIONAL UK LIMITED (GB) | 2016-07-05 | — | — | US | claimed |
| US-20150099896-A1 | CONTINUOUS PROCESS FOR THE CARBONYLATION OF ETHYLENE | LUCITE INTERNATIONAL UK LIMITED (GB) | 2015-04-09 | — | — | US | claimed |
| EP-1931471-B1 | CONTINUOUS CARBONYLATION PROCESS | LUCITE INT UK LTD (GB) | 2014-10-01 | — | — | EP | claimed |
| EP-2007703-B1 | METAL COMPLEXES FOR USE IN THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | LUCITE INT UK LTD (GB) | 2013-12-18 | — | — | EP | claimed |
| US-8604236-B2 | Catalyst system | LUCITE INTERNATIONAL UK LIMITED (GB) | 2013-12-10 | — | — | US | claimed |
| US-8445711-B2 | Metal complexes | LUCITE INTERNATIONAL UK LIMITED (GB) | 2013-05-21 | — | — | US | claimed |
| US-20100197958-A1 | PROCESS FOR THE CARBONYLATION OF AN ETHYLENICALLY UNSATURATED COMPOUND AND A CATALYST SYSTEM | LUCITE INTERNATIONAL UK LIMITED (GB) | 2010-08-05 | — | — | US | claimed |
| US-20090312561-A1 | METAL COMPLEXES | LUCITE INTERNATIONAL UK LIMITED (GB) | 2009-12-17 | — | — | US | claimed |
| US-20090216041-A1 | Catalyst System | LUCITE INTERNATIONAL UK LIMITED (GB) | 2009-08-27 | — | — | US | claimed |
| EP-2513031-B1 | A CONTINUOUS PROCESS FOR THE CARBONYLATION OF ETHYLENE | LUCITE INT UK LTD (GB) | 2018-08-22 | — | — | EP | disclosed |
| US-9382190-B2 | Continuous process for the carbonylation of ethylene | LUCITE INTERNATIONAL UK LIMITED (GB) | 2016-07-05 | — | — | US | disclosed |
| US-9138694-B2 | Mixing apparatus | LUCITE INTERNATIONAL UK LIMITED (GB) | 2015-09-22 | — | — | US | disclosed |
| EP-1931471-B1 | CONTINUOUS CARBONYLATION PROCESS | LUCITE INT UK LTD (GB) | 2014-10-01 | — | — | EP | disclosed |
| US-8785678-B2 | Continuous process for the carbonylation of ethylene | LUCITE INTERNATIONAL UK LIMITED (GB) | 2014-07-22 | — | — | US | disclosed |
| US-20090216041-A1 | Catalyst System | LUCITE INTERNATIONAL UK LIMITED (GB) | 2009-08-27 | — | — | US | disclosed |
| US-20090208390-A1 | MIXING APPARATUS | LUCITE INTERNATIONAL UK LIMITED (GB) | 2009-08-20 | — | — | US | disclosed |
| WO-2008075108-A1 | CARBONYLATION OF CONJUGATED DIENES | LUCITE INTERNATIONAL UK LIMITED (GB) | 2008-06-26 | — | — | WO | disclosed |
| EP-1931471-A1 | IMPROVED CATALYST SYSTEM | Lucite International UK Limited (GB) | 2008-06-18 | — | — | EP | disclosed |
| WO-2007020379-A1 | IMPROVED CATALYST SYSTEM | LUCITE INTERNATIONAL UK LIMITED (GB) | 2007-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099896-A1 | CONTINUOUS PROCESS FOR THE CARBONYLATION OF ETHYLENE | SCD, ELOVL6, ALK | P2RX7 4835/4885 |
| US-20090216041-A1 | Catalyst System | CBS, SMS, POF1B | P2RX7 4126/4885 |
| US-20100197958-A1 | PROCESS FOR THE CARBONYLATION OF AN ETHYLENICALLY UNSATURATED COMPOUND AND A CATALYST SYSTEM | ALOX5, ACSL5, ELOVL5 | P2RX7 2931/4885 |
| US-20090312561-A1 | METAL COMPLEXES | MLX, PICALM, AP2M1 | P2RX7 237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.